Overprescription of short‐acting β<sub>2</sub>‐agonists among patients with asthma in Saudi Arabia: Results from the SABINA III cohort study
Hamdan Al‐Jahdali(King Saud University), Maarten Beekman(The Netherlands Cancer Institute), Abdulmajed Arwadi(Riyadh Armed Forces Hospital), Siraj Wali(King Abdulaziz University), Amr S. Albanna(King Saud bin Abdulaziz University for Health Sciences), Tarek Dahan(King Fahad Specialist Hospital), Ezzat Hamza(AstraZeneca (Singapore)), Riyad Al‐Lehebi(Alfaisal University), Mohamed Fattouh, Abeer Al Harbi(King Fahad Hospital Jeddah)
Cited by 8
Related Papers
Role of Transforming Growth Factor–β in Airway Remodeling in Asthma
|American Journal of Respiratory Cell and Molecular Biology|2010|420
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
|New England Journal of Medicine|2018|392
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations
|The Lancet Respiratory Medicine|2021|297
Histopathology of Middle East respiratory syndrome coronovirus (<scp>MERS</scp>‐CoV) infection – clinicopathological and ultrastructural study
|Histopathology|2017|290
Improper inhaler technique is associated with poor asthma control and frequent emergency department visits
|Allergy Asthma and Clinical Immunology|2013|283